Review of observational data links semaglutide and tirzepatide to survival in breast cancer
Semaglutide linked to lower death rates in breast cancer patients compared to other diabetes drugs
This review synthesized observational, propensity-matched analyses of patients with pre-existing breast cancer. It reported improved overall…
In routine care, semaglutide users with breast cancer had significantly lower death rates and less metastatic disease than those on other co…
Preclinical deep learning framework shows improved dose prediction for unseen cancer sites
A Heavy Burden on Doctors
This is a preclinical development study of a deep learning framework for radiotherapy dose prediction. The framework performed comparably to…
A new AI tool can plan radiation doses for many different cancers at once.
Narrative review discusses mitochondria and immune crosstalk in breast cancer patients.
Mitochondria and immune cells interact in complex ways for breast cancer patients.
This narrative review explores the role of mitochondrial biology and immune crosstalk in breast cancer. The authors note that metabolic hete…
Mitochondrial biology and immune system interactions represent a complex, context-dependent factor in breast cancer that requires careful co…
High-dose dexamethasone during chemotherapy shows no significant cortisol changes in breast cancer.
Chemotherapy Steroids May Not Shut Down Your Body’s Stress System
This prospective pilot study included 47 women with breast cancer receiving paclitaxel and dexamethasone. Morning serum cortisol and adrenoc…
This small study suggests that the body’s natural ability to make stress hormones might stay intact during certain chemotherapy regimens, ea…
Breast cancer chemotherapy associated with taste alterations and dietary changes in Italian cohort
Chemo Taste Changes: Patients Feel More Than Tests Detect
This prospective observational cohort study evaluated female patients with breast cancer undergoing chemotherapy at Candiolo Cancer Institut…
New research shows chemotherapy changes how food tastes, but standard tests might not catch it all.
FDA Approves Ontruzant (trastuzumab-dttb) for HER2-Overexpressing Breast and Gastric Cancers
FDA approves new cancer drug called Ontruzant for certain breast and stomach cancers
Ontruzant (trastuzumab-dttb) is approved for HER2-overexpressing breast cancer and metastatic gastric or gastroesophageal junction adenocarc…
The FDA has approved a new drug called Ontruzant for treating certain breast and stomach cancers. It works for cancers that have too much of…
Narrative review examines PAMAM dendrimers as carriers of natural compounds for breast cancer preclinical applications
New Nanoparticles Could Make Plant-Based Cancer Drugs Work Better
This narrative review explores the use of PAMAM dendrimers as carriers of natural compounds in preclinical settings for breast cancer. The a…
Tiny nanoparticles could help plant-based medicines fight breast cancer more effectively by delivering natural compounds directly to tumors.
Multi-phase DCE-MRI delta-radiomics predicts Ki-67 changes in 148 breast cancer patients after neoadjuvant therapy.
MRI features may help predict Ki-67 changes in breast cancer after treatment
This retrospective cohort study evaluated 148 breast cancer patients who underwent surgical resection after 6–8 cycles of neoadjuvant therap…
A new MRI analysis predicts Ki-67 changes in breast cancer after treatment with 82% accuracy, outperforming simpler models that were only 62…
FDA Approves Itovebi (Itovebi) for Endocrine-Resistant, PIK3CA-Mutated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
FDA approves new breast cancer drug Itovebi for a specific type of advanced cancer.
The FDA approved Itovebi in combination with palbociclib and fulvestrant for adults with endocrine-resistant, PIK3CA-mutated, HR-positive, H…
A new oral drug, Itovebi, is now FDA-approved for advanced breast cancer with a specific genetic mutation, offering another option when horm…
Perioperative Propranolol and Etodolac Safety and 8-Year Survival in Cancer Patients
Safe Drug Combo May Help Cancer Patients Heal Faster
This randomized controlled trial evaluated perioperative propranolol and etodolac in 148 patients with breast, colorectal, and pancreatic ca…
A safe drug mix of propranolol and etodolac helps breast, colorectal, and pancreatic cancer patients heal faster after surgery without causi…
Adjunctive Chinese herbal medicine associated with symptom improvement in 83 breast cancer patients receiving Western medicine.
Herbs May Ease Breast Cancer Symptoms
This prospective observational study evaluated 83 patients with breast cancer receiving Western medicine alongside adjunctive scientific Chi…
Women using Chinese herbs alongside breast cancer treatment reported less fatigue, fewer hot flashes, and less pain compared to those taking…
Peer-led blended peer support program improves psychosocial adjustment in young- to middle-aged breast cancer patients
Can a peer support program help young breast cancer patients cope better after surgery?
In a single-center cluster RCT of 70 young- to middle-aged breast cancer patients, an 8-week peer-led, nurse-involved blended peer support p…
An 8-week peer support program helped young breast cancer patients feel more socially supported and face problems head-on after surgery.